Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleResearch Letter

Communication of Drug Efficacy Information via a Popular Online Platform

Jonathan J. Darrow and Elizaveta Borisova
The Journal of the American Board of Family Medicine July 2022, 35 (4) 833-835; DOI: https://doi.org/10.3122/jabfm.2022.04.210539
Jonathan J. Darrow
From Program On Regulation, Therapeutics, And Law (PORTAL), Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; Department of Law & Taxation, Bentley University, Waltham, MA, USA; and McCallum Graduate School of Business, Bentley University, Waltham, MA, USA.
SJD, LLM, JD, MBA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizaveta Borisova
From Program On Regulation, Therapeutics, And Law (PORTAL), Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; Department of Law & Taxation, Bentley University, Waltham, MA, USA; and McCallum Graduate School of Business, Bentley University, Waltham, MA, USA.
BS, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Open-source online information channels have become increasingly important to the dissemination of medical information, including information about pharmaceuticals. We sought to determine the extent to which one prominent source of online information, Wikipedia, presented quantitative efficacy data about drugs.

Methods: Using the Drugs@FDA website, we identified all new drugs approved by the Food and Drug Administration (FDA) from 1982 to 2020 and their associated Wikipedia pages, and used dummy variables to code for the presence of efficacy data, safety data, and usage data.

Results: Approximately 98% of 1201 drugs approved from 1982 to 2020 had Wikipedia pages. While most pages provided indirect indicia of efficacy, such as indication (98%) or mechanism of action (86%), fewer (21%) quantified evidence of benefit. Wikipedia drug pages were associated with indicia of high impact, including a median of more than 23,000 annual page views.

Conclusion: Wikipedia is an important source of information that has the potential to shape public views about drug efficacy, but the absence of quantitative efficacy information in most pages limits public understanding of the benefits that drugs actually offer.

  • Evidence-Based Medicine
  • Health Communication
  • Internet
  • Pharmaceutical Preparations

Introduction

Despite the centrality of peer-reviewed literature to medicine, alternative channels for communicating drug information have risen dramatically in importance. By 2013, 94% of medical students1 and nearly 50% of US physicians who went online for professional purposes used Wikipedia, and 72% of Americans with Internet access searched online for health information.2,3 The Cochrane Collaboration considers Wikipedia an important means for disseminating evidence,4 and a 2014 study by IMS Health (now IQVIA) found that prescription volume was highly correlated with Wikipedia searches (R2 = 0.87).2 Nevertheless, little is known about the extent to which Wikipedia discloses drug efficacy or safety information, or how frequently its drug pages are viewed.

Objective

We examined the content and usage of Wikipedia drug pages to provide insight into their potential impact on public perception of the therapeutic value of drugs.

Methods

Using the Drugs@FDA website, we identified all new drugs approved by the Food and Drug Administration (FDA) from 1982 to 2020 and their associated Wikipedia pages, which were downloaded in January 2021. From each page, we extracted indication, quantitative efficacy measures, comparative effectiveness claims, mechanism of action, FDA approval status, quantitative measures of evidence, mentions of adverse events, and quantitative measures of adverse events. We also extracted webpage views during calendar year 2020, and the number of page edits, editors, and Internet links from other webpages.

Results

From 1982 to 2020, the FDA approved 1201 drugs. Of these, 1169 (97%) were associated with 1 Wikipedia page (Figure 1), and 10 (0.9%) with multiple pages. Most pages disclosed at least 1 indication (98%, 1149/1169), mechanism of action (86%, 1011/1169), and status as FDA-approved (67%, 779/1169). Other disclosures potentially related to perceptions of therapeutic value included comparative effectiveness information (14%, 160/1169), and the presence of “significant” benefit (8%, 93/1169). Just 21% (249/1169) quantified the evidence of benefit, and 17% (203/1169) the magnitude of benefit. Seventy-seven percent (897/1169) mentioned at least 1 adverse event and 31% (366/1169) quantified the frequency of at least 1 adverse event.

Figure 1.
  • Download figure
  • Open in new tab
Figure 1.

Frequency of benefit and risk information in wikipedia drug pages for drugs approved by the Food and Drug Administration (FDA), 1982 to 2020 (as of January 2021).

Wikipedia drug pages had a median of 137 (interquartile range [IQR]: 70 to 268) edits, 68.5 (IQR: 38 to 133) editors, 285 (IQR: 125 to 508) links from other Wikipedia pages, 50 (IQR: 31 to 89) links from non-Wikipedia pages, and 23,829 (IQR: 9729 to 71,757) page views in 2020. The median share of edits made by the top 10% of editors was 40% (IQR: 30 to 53%).

Discussion

Wikipedia has the potential to substantially influence public thought about drug efficacy. Nearly all (98%) drugs FDA-approved since 1982 were described in a dedicated Wikipedia page, and most (77%) drugs listed in the FDA's Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) were approved in 1990 or later.5 Most Wikipedia drug pages have hundreds of links that lead to them, including from both external websites and other Wikipedia pages, and receive tens of thousands of page views per year.

Pages nearly always contained indicia suggestive of meaningful therapeutic benefit, but quantitative measures of benefit (17%) or evidence of benefit (21%) were infrequent. Common indicia included: statements of indication (98%), suggesting medical consensus that a drug is sufficiently valuable to treat the indicated condition; mechanism of action (86%), offering a scientific rationale for how a drug achieves its effect; and FDA-approval status (67%), representing a formal endorsement by the government's expert drugs agency, despite the absence of any minimum net benefit threshold (other than nonzero) required for approval.6 Collectively, these findings suggest that Wikipedia could contribute to perceptions of therapeutic value that may not be justified by objective measures. Practicing family physicians should therefore be prepared to correct any misimpressions by communicating the extent of benefit a drug is likely to offer before obtaining informed treatment consent from patients.

The dozens of editors associated with most Wikipedia drug pages suggest broad input that reflects the design of Wikipedia as a collaborative platform. However, the use of pseudonyms makes the identification of editors challenging, and it is possible that the use of proxy servers or other techniques could further obscure identities. Previous work has raised concerns about conflicts of interest, finding that some editors of Wikipedia drug pages seem to have ties to industry.7 We found that a small number of editors often contributes a large share of edits, potentially magnifying the impact of any bias.

Given Wikipedia's collaborative nature and potential to influence perceptions of drug benefit, physicians and public health experts could improve public understanding by adding quantitative, unbiased, and scientifically-verified measures of efficacy to Wikipedia drug pages whenever they are able to do so, such as those provided within the FDA's approval documents.8 In the longer term, a university-based organization could be established to assemble students of medicine or public health in an ongoing effort to ensure that measures of therapeutic benefit described on Wikipedia drug pages are current, reliable, and clearly disclosed.

Limitations

Only English-language Wikipedia pages were examined. Wikipedia's non-English language drug pages may substantially enlarge the impact of Wikipedia, and may not present the same information as their English-language counterparts. Median numbers of links, edits, and editors per page were not adjusted for the differing durations since approval.

Acknowledgments

The authors thank Aaron Kesselheim for helpful comments.

Notes

  • This article was externally peer reviewed.

  • Funding: This project was funded by a Bentley University Faculty Affairs Committee grant (grant number: not applicable). The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Dr. Darrow also receives research support from Health Action International's program on Addressing the Challenge and Constraints of Insulin Sources and Supply (ACCISS), Arnold Ventures, the Commonwealth Fund, the Greenwall Foundation, the Kaiser Permanente Institute for Health Policy, West Health, and under a Novo Nordisk Foundation grant for a scientifically independent Collaborative Research Programme (grant NNF17SA0027784).

  • Conflict of interest: None.

  • To see this article online, please go to: http://jabfm.org/content/35/4/833.full.

  • Received for publication December 30, 2021.
  • Revision received March 16, 2022.
  • Accepted for publication March 25, 2022.

References

  1. 1.↵
    1. Allahwala UK,
    2. Nadkarni A,
    3. Sebaratnam DF
    . Wikipedia use amongst medical students: new insights into the digital revolution. Med Teach 2013;35:337.
    OpenUrl
  2. 2.↵
    Engaging patients through social media: is healthcare ready for empowered and digitally demanding patients? (2014). Available at https://fdocuments.in/document/social-media-in-healthcare-report-2014.html.
  3. 3.↵
    1. Smith DA
    . Situating Wikipedia as a health information resource in various contexts: a scoping review. PLoS ONE 2020;15:e0228786.
    OpenUrlCrossRef
  4. 4.↵
    1. de Haan S
    . Wikipedia: an important dissemination tool for Cochrane. March 1, 2017. Available at https://community.cochrane.org/news/wikipedia-important-dissemination-tool-cochrane.
  5. 5.↵
    FDA. Approved drug products with therapeutic equivalence evaluations (40th ed. 2020). Available at http://www.fdalawblog.net/wp-content/uploads/2020/06/OB-Annual-2020-40th-Ed.pdf.
  6. 6.↵
    1. Darrow JJ
    . Pharmaceutical efficacy: the illusory legal standard. Washington & Lee Law Review 2013;70:2073–136.
    OpenUrl
  7. 7.↵
    1. Skancke KH,
    2. Svendsen K
    . Wikipedia and medicines: who edits medicine articles on the English Wikipedia? Int J Clin Pharm 2017;39:254.
    OpenUrl
  8. 8.↵
    FDA. Drugs@FDA: FDA-approved drugs. Available at https://www.accessdata.fda.gov/scripts/cder/daf/.
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family     Medicine: 35 (4)
The Journal of the American Board of Family Medicine
Vol. 35, Issue 4
July/August 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Communication of Drug Efficacy Information via a Popular Online Platform
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Communication of Drug Efficacy Information via a Popular Online Platform
Jonathan J. Darrow, Elizaveta Borisova
The Journal of the American Board of Family Medicine Jul 2022, 35 (4) 833-835; DOI: 10.3122/jabfm.2022.04.210539

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Communication of Drug Efficacy Information via a Popular Online Platform
Jonathan J. Darrow, Elizaveta Borisova
The Journal of the American Board of Family Medicine Jul 2022, 35 (4) 833-835; DOI: 10.3122/jabfm.2022.04.210539
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Objective
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Family Medicine Researchers Explore the Social Determinants of Health, COVID-19 Issues, and Cancer Survivor Care
  • Google Scholar

More in this TOC Section

  • Timing of Certification Stage Completion Associated with Subsequent Certification Exam Outcomes Among Board-Certified Family Physicians
  • Interpersonal Continuity of Care May Help Delay Progression to Type 2 Diabetes
  • Impact of Point of Care Hemoglobin A1c Testing on Time to Therapeutic Intervention
Show more Research Letters

Similar Articles

Keywords

  • Evidence-Based Medicine
  • Health Communication
  • Internet
  • Pharmaceutical Preparations

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire